In Vivo Gene Delivery Using Exosomes Engineered to Contain AAV Improves Transduction Efficiency and Resists Neutralizing Antibodies

被引：0
|
作者：
McConnell, Russell [1 ]
Lule, Sevda [1 ]
Zi, Tong [1 ]
Jang, Su Chul [1 ]
Noyes, Aaron [1 ]
Sathy, Sriram [1 ]
机构：
[1] Codiak BioSci, Cambridge, MA USA
来源：
MOLECULAR THERAPY | 2023年 / 31卷 / 04期
关键词：
D O I：
暂无
中图分类号：
Q81 [生物工程学（生物技术）]; Q93 [微生物学];
学科分类号：
071005 ; 0836 ; 090102 ; 100705 ;
摘要：
461
引用
收藏
页码：237 / 238
页数：2
相关论文
共 50 条
  • [31] Site-Directed Mutagenesis of an Engineered AAV3 Capsid Variant, LK-03, Improves Its Transduction Efficiency in Human Hepatic Cells In Vitro and in a Xenograft Murine Model In Vivo
    Zhang, Daniel
    Zhang, Yuanhui
    Li, Jun
    Ling, Chen
    Srivastava, Arun
    MOLECULAR THERAPY, 2017, 25 (05) : 259 - 259
  • [32] A Novel Engineered AAV2 Capsid Variant CereAAV™ for Efficient In Vivo Gene Transduction into Mouse Brain Neurons and Microvascular Endothelial Cells
    Tanaka, Yoshinori
    Nariki, Hiroaki
    Ueda, Sayuri
    Tanaka, Rina
    Nishie, Toshikazu
    Takashima, Fuyuko
    Okamoto, Sachiko
    Enoki, Tatsuji
    Mineno, Junichi
    MOLECULAR THERAPY, 2022, 30 (04) : 67 - 68
  • [33] Neutralizing antibodies against AAV2, AAV5 and AAV8 in healthy and HIV-1-infected subjects in China: implications for gene therapy using AAV vectors
    Liu, Q.
    Huang, W.
    Zhang, H.
    Wang, Y.
    Zhao, J.
    Song, A.
    Xie, H.
    Zhao, C.
    Gao, D.
    Wang, Y.
    GENE THERAPY, 2014, 21 (08) : 732 - 738
  • [34] Neutralizing antibodies against AAV2, AAV5 and AAV8 in healthy and HIV-1-infected subjects in China: implications for gene therapy using AAV vectors
    Q Liu
    W Huang
    H Zhang
    Y Wang
    J Zhao
    A Song
    H Xie
    C Zhao
    D Gao
    Y Wang
    Gene Therapy, 2014, 21 : 732 - 738
  • [35] Xork-Fc, an Engineered IgG Protease, Shows Low Cross-Reactivity to Pre-Existing Antibodies in Human Serum and Enables Efficient AAV Transduction in an In Vivo Model of Passive Transfer of Neutralizing Human Serum
    Li, Ning
    Michaud, Alicia M.
    Capela, Teresa
    Yu, Houqing
    Ge, Jingping
    Swami, Pooja
    Nordgren, Maria
    Lood, Rolf
    Leung, Sheldon S.
    Ilyinskii, Petr O.
    Kishimoto, Kei
    MOLECULAR THERAPY, 2023, 31 (04) : 364 - 364
  • [36] Impact of Vital Dyes on Cell Viability and Transduction Efficiency of AAV Vectors Used in Retinal Gene Therapy Surgery: An In Vitro and In Vivo Analysis
    Salvetti, Anna P.
    Patricio, Maria I.
    Barnard, Alun R.
    Orlans, Harry O.
    Hickey, Doron G.
    MacLaren, Robert E.
    TRANSLATIONAL VISION SCIENCE & TECHNOLOGY, 2017, 6 (04):
  • [37] Delivery of Large Gene Circuits In Vivo Using an Engineered Baculovirus Vector for Multifactorial Control of Therapeutic Gene Expression
    Brown, Lucas B. C.
    Zhang, Linlin
    Bao, Gang
    Bashor, Caleb J.
    MOLECULAR THERAPY, 2024, 32 (04) : 87 - 88
  • [38] Developing new AAV-based tools capable of high efficiency gene delivery for in vivo reprogramming Muller glia cells
    Xie, Ye
    Zhou, Jing
    Chen, Bo
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2023, 64 (08)
  • [39] Targeted Modifications in Adeno-Associated Virus Serotype (AAV)-8 Capsid Improves Its Hepatic Gene Transfer Efficiency in Vivo
    Sen, Dwaipayan
    Gabriel, Nishanth
    Yesupatham, Sathish Kumar
    Samuel, Rekha
    Gadkari, Rupali A.
    Sudha, G.
    Srinivasan, N.
    Srivastava, Alok
    Jayandharan, Giridhara Rao
    BLOOD, 2012, 120 (21)
  • [40] Gene delivery GAD500 autoantigen by AAV serotype 1 prevented diabetes in NOD mice:: Transduction efficiency do not play important roles
    Han, Gencheng
    Wang, Renxi
    Chen, Guojiang
    Wang, Ranan
    Xu, Ruonan
    Feng, Jiannan
    Yu, Ming
    Wu, Xiaobing
    Qian, Jiahua
    Shen, Beifen
    Li, Yan
    IMMUNOLOGY LETTERS, 2008, 115 (02) : 110 - 116
12345